nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—Niclosamide—STAT3—ovarian cancer	0.0318	0.957	CrCbGaD
Diflunisal—PTGS2—ovarian follicle—ovarian cancer	0.0308	0.22	CbGeAlD
Diflunisal—PTGS1—oviduct—ovarian cancer	0.0142	0.101	CbGeAlD
Diflunisal—TTR—embryo—ovarian cancer	0.012	0.0857	CbGeAlD
Diflunisal—TTR—female reproductive system—ovarian cancer	0.00727	0.052	CbGeAlD
Diflunisal—TTR—bone marrow—ovarian cancer	0.00686	0.049	CbGeAlD
Diflunisal—TTR—testis—ovarian cancer	0.00586	0.0419	CbGeAlD
Diflunisal—PTGS2—myometrium—ovarian cancer	0.00433	0.031	CbGeAlD
Diflunisal—PTGS2—embryo—ovarian cancer	0.00417	0.0298	CbGeAlD
Diflunisal—ALB—testis—ovarian cancer	0.00374	0.0268	CbGeAlD
Diflunisal—PTGS1—epithelium—ovarian cancer	0.00356	0.0254	CbGeAlD
Diflunisal—PTGS1—uterine cervix—ovarian cancer	0.00353	0.0252	CbGeAlD
Diflunisal—PTGS2—epithelium—ovarian cancer	0.0034	0.0243	CbGeAlD
Diflunisal—PTGS2—uterine cervix—ovarian cancer	0.00337	0.0241	CbGeAlD
Diflunisal—PTGS1—endometrium—ovarian cancer	0.00319	0.0228	CbGeAlD
Diflunisal—PTGS2—endometrium—ovarian cancer	0.00305	0.0218	CbGeAlD
Diflunisal—PTGS1—uterus—ovarian cancer	0.00294	0.021	CbGeAlD
Diflunisal—PTGS2—uterus—ovarian cancer	0.00281	0.0201	CbGeAlD
Diflunisal—ALB—lymph node—ovarian cancer	0.00271	0.0194	CbGeAlD
Diflunisal—PTGS1—female reproductive system—ovarian cancer	0.00264	0.0189	CbGeAlD
Diflunisal—PTGS2—female reproductive system—ovarian cancer	0.00253	0.0181	CbGeAlD
Diflunisal—PTGS1—female gonad—ovarian cancer	0.0024	0.0172	CbGeAlD
Diflunisal—PTGS1—vagina—ovarian cancer	0.00239	0.0171	CbGeAlD
Diflunisal—PTGS2—bone marrow—ovarian cancer	0.00238	0.0171	CbGeAlD
Diflunisal—PTGS2—female gonad—ovarian cancer	0.0023	0.0164	CbGeAlD
Diflunisal—PTGS2—vagina—ovarian cancer	0.00228	0.0163	CbGeAlD
Diflunisal—PTGS1—testis—ovarian cancer	0.00213	0.0153	CbGeAlD
Diflunisal—Gastrointestinal pain—Topotecan—ovarian cancer	0.00211	0.00316	CcSEcCtD
Diflunisal—Anorexia—Vinorelbine—ovarian cancer	0.0021	0.00315	CcSEcCtD
Diflunisal—Asthenia—Chlorambucil—ovarian cancer	0.00208	0.00311	CcSEcCtD
Diflunisal—Pruritus—Chlorambucil—ovarian cancer	0.00205	0.00307	CcSEcCtD
Diflunisal—Urticaria—Topotecan—ovarian cancer	0.00205	0.00307	CcSEcCtD
Diflunisal—Body temperature increased—Topotecan—ovarian cancer	0.00204	0.00305	CcSEcCtD
Diflunisal—Visual impairment—Paclitaxel—ovarian cancer	0.00201	0.00302	CcSEcCtD
Diflunisal—Urticaria—Melphalan—ovarian cancer	0.00201	0.00301	CcSEcCtD
Diflunisal—Diarrhoea—Chlorambucil—ovarian cancer	0.00198	0.00297	CcSEcCtD
Diflunisal—Paraesthesia—Vinorelbine—ovarian cancer	0.00198	0.00297	CcSEcCtD
Diflunisal—Erythema multiforme—Paclitaxel—ovarian cancer	0.00197	0.00296	CcSEcCtD
Diflunisal—Dyspnoea—Vinorelbine—ovarian cancer	0.00197	0.00295	CcSEcCtD
Diflunisal—Photosensitivity—Epirubicin—ovarian cancer	0.00197	0.00294	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Docetaxel—ovarian cancer	0.00196	0.00293	CcSEcCtD
Diflunisal—Tinnitus—Paclitaxel—ovarian cancer	0.00195	0.00292	CcSEcCtD
Diflunisal—Renal failure—Docetaxel—ovarian cancer	0.00194	0.0029	CcSEcCtD
Diflunisal—Flushing—Paclitaxel—ovarian cancer	0.00194	0.0029	CcSEcCtD
Diflunisal—Jaundice—Docetaxel—ovarian cancer	0.00192	0.00288	CcSEcCtD
Diflunisal—Stomatitis—Docetaxel—ovarian cancer	0.00192	0.00288	CcSEcCtD
Diflunisal—Decreased appetite—Vinorelbine—ovarian cancer	0.00192	0.00287	CcSEcCtD
Diflunisal—Fatigue—Vinorelbine—ovarian cancer	0.0019	0.00285	CcSEcCtD
Diflunisal—Hypersensitivity—Topotecan—ovarian cancer	0.0019	0.00285	CcSEcCtD
Diflunisal—Constipation—Vinorelbine—ovarian cancer	0.00189	0.00283	CcSEcCtD
Diflunisal—Hypersensitivity—Melphalan—ovarian cancer	0.00186	0.00279	CcSEcCtD
Diflunisal—Asthenia—Topotecan—ovarian cancer	0.00185	0.00277	CcSEcCtD
Diflunisal—Vomiting—Chlorambucil—ovarian cancer	0.00184	0.00276	CcSEcCtD
Diflunisal—Agranulocytosis—Docetaxel—ovarian cancer	0.00184	0.00276	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.00183	0.00274	CcSEcCtD
Diflunisal—Pruritus—Topotecan—ovarian cancer	0.00182	0.00273	CcSEcCtD
Diflunisal—Photosensitivity—Doxorubicin—ovarian cancer	0.00182	0.00272	CcSEcCtD
Diflunisal—Feeling abnormal—Vinorelbine—ovarian cancer	0.00182	0.00272	CcSEcCtD
Diflunisal—Renal impairment—Epirubicin—ovarian cancer	0.00181	0.00272	CcSEcCtD
Diflunisal—Asthenia—Melphalan—ovarian cancer	0.00181	0.00271	CcSEcCtD
Diflunisal—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.0018	0.0027	CcSEcCtD
Diflunisal—Flatulence—Paclitaxel—ovarian cancer	0.00179	0.00268	CcSEcCtD
Diflunisal—Pruritus—Melphalan—ovarian cancer	0.00179	0.00268	CcSEcCtD
Diflunisal—Tension—Paclitaxel—ovarian cancer	0.00178	0.00267	CcSEcCtD
Diflunisal—Hepatitis—Docetaxel—ovarian cancer	0.00177	0.00265	CcSEcCtD
Diflunisal—Nervousness—Paclitaxel—ovarian cancer	0.00177	0.00265	CcSEcCtD
Diflunisal—Diarrhoea—Topotecan—ovarian cancer	0.00176	0.00264	CcSEcCtD
Diflunisal—Urticaria—Vinorelbine—ovarian cancer	0.00175	0.00263	CcSEcCtD
Diflunisal—Muscle spasms—Paclitaxel—ovarian cancer	0.00175	0.00262	CcSEcCtD
Diflunisal—Body temperature increased—Vinorelbine—ovarian cancer	0.00174	0.00261	CcSEcCtD
Diflunisal—Diarrhoea—Melphalan—ovarian cancer	0.00173	0.00259	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Epirubicin—ovarian cancer	0.00173	0.00259	CcSEcCtD
Diflunisal—Nausea—Chlorambucil—ovarian cancer	0.00172	0.00258	CcSEcCtD
Diflunisal—Vision blurred—Paclitaxel—ovarian cancer	0.00171	0.00257	CcSEcCtD
Diflunisal—Visual impairment—Docetaxel—ovarian cancer	0.00171	0.00256	CcSEcCtD
Diflunisal—Dizziness—Topotecan—ovarian cancer	0.00171	0.00255	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.00169	0.00254	CcSEcCtD
Diflunisal—Renal impairment—Doxorubicin—ovarian cancer	0.00168	0.00251	CcSEcCtD
Diflunisal—Erythema multiforme—Docetaxel—ovarian cancer	0.00167	0.00251	CcSEcCtD
Diflunisal—Angioedema—Paclitaxel—ovarian cancer	0.00166	0.00249	CcSEcCtD
Diflunisal—Flushing—Docetaxel—ovarian cancer	0.00164	0.00246	CcSEcCtD
Diflunisal—Vomiting—Topotecan—ovarian cancer	0.00164	0.00246	CcSEcCtD
Diflunisal—Vertigo—Paclitaxel—ovarian cancer	0.00163	0.00245	CcSEcCtD
Diflunisal—Syncope—Paclitaxel—ovarian cancer	0.00163	0.00244	CcSEcCtD
Diflunisal—Rash—Topotecan—ovarian cancer	0.00163	0.00244	CcSEcCtD
Diflunisal—Hypersensitivity—Vinorelbine—ovarian cancer	0.00163	0.00243	CcSEcCtD
Diflunisal—Dermatitis—Topotecan—ovarian cancer	0.00162	0.00243	CcSEcCtD
Diflunisal—Headache—Topotecan—ovarian cancer	0.00162	0.00242	CcSEcCtD
Diflunisal—Palpitations—Paclitaxel—ovarian cancer	0.00161	0.00241	CcSEcCtD
Diflunisal—Vomiting—Melphalan—ovarian cancer	0.00161	0.00241	CcSEcCtD
Diflunisal—Loss of consciousness—Paclitaxel—ovarian cancer	0.0016	0.00239	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Doxorubicin—ovarian cancer	0.0016	0.00239	CcSEcCtD
Diflunisal—Rash—Melphalan—ovarian cancer	0.00159	0.00239	CcSEcCtD
Diflunisal—Dermatitis—Melphalan—ovarian cancer	0.00159	0.00238	CcSEcCtD
Diflunisal—Asthenia—Vinorelbine—ovarian cancer	0.00158	0.00237	CcSEcCtD
Diflunisal—Pruritus—Vinorelbine—ovarian cancer	0.00156	0.00234	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00155	0.00233	CcSEcCtD
Diflunisal—Chest pain—Paclitaxel—ovarian cancer	0.00155	0.00232	CcSEcCtD
Diflunisal—PTGS1—lymph node—ovarian cancer	0.00155	0.0111	CbGeAlD
Diflunisal—Nausea—Topotecan—ovarian cancer	0.00153	0.00229	CcSEcCtD
Diflunisal—Gastritis—Epirubicin—ovarian cancer	0.00153	0.00229	CcSEcCtD
Diflunisal—Diarrhoea—Vinorelbine—ovarian cancer	0.00151	0.00226	CcSEcCtD
Diflunisal—Nausea—Melphalan—ovarian cancer	0.0015	0.00225	CcSEcCtD
Diflunisal—Confusional state—Paclitaxel—ovarian cancer	0.0015	0.00224	CcSEcCtD
Diflunisal—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00148	0.00222	CcSEcCtD
Diflunisal—Oedema—Paclitaxel—ovarian cancer	0.00148	0.00222	CcSEcCtD
Diflunisal—Muscle spasms—Docetaxel—ovarian cancer	0.00148	0.00222	CcSEcCtD
Diflunisal—PTGS2—lymph node—ovarian cancer	0.00148	0.0106	CbGeAlD
Diflunisal—Shock—Paclitaxel—ovarian cancer	0.00146	0.00219	CcSEcCtD
Diflunisal—Dizziness—Vinorelbine—ovarian cancer	0.00146	0.00219	CcSEcCtD
Diflunisal—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00145	0.00218	CcSEcCtD
Diflunisal—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00144	0.00215	CcSEcCtD
Diflunisal—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00143	0.00215	CcSEcCtD
Diflunisal—Salicylic acid—ABCB1—ovarian cancer	0.00142	0.0429	CrCbGaD
Diflunisal—Anorexia—Paclitaxel—ovarian cancer	0.00141	0.00212	CcSEcCtD
Diflunisal—Gastritis—Doxorubicin—ovarian cancer	0.00141	0.00212	CcSEcCtD
Diflunisal—Vomiting—Vinorelbine—ovarian cancer	0.0014	0.0021	CcSEcCtD
Diflunisal—Dysuria—Epirubicin—ovarian cancer	0.0014	0.00209	CcSEcCtD
Diflunisal—Rash—Vinorelbine—ovarian cancer	0.00139	0.00208	CcSEcCtD
Diflunisal—Dermatitis—Vinorelbine—ovarian cancer	0.00139	0.00208	CcSEcCtD
Diflunisal—Headache—Vinorelbine—ovarian cancer	0.00138	0.00207	CcSEcCtD
Diflunisal—Syncope—Docetaxel—ovarian cancer	0.00138	0.00207	CcSEcCtD
Diflunisal—Palpitations—Docetaxel—ovarian cancer	0.00136	0.00204	CcSEcCtD
Diflunisal—Photosensitivity reaction—Epirubicin—ovarian cancer	0.00136	0.00204	CcSEcCtD
Diflunisal—Loss of consciousness—Docetaxel—ovarian cancer	0.00135	0.00203	CcSEcCtD
Diflunisal—Insomnia—Paclitaxel—ovarian cancer	0.00134	0.00201	CcSEcCtD
Diflunisal—Paraesthesia—Paclitaxel—ovarian cancer	0.00133	0.002	CcSEcCtD
Diflunisal—Dyspnoea—Paclitaxel—ovarian cancer	0.00132	0.00198	CcSEcCtD
Diflunisal—Somnolence—Paclitaxel—ovarian cancer	0.00132	0.00198	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.00132	0.00198	CcSEcCtD
Diflunisal—Chest pain—Docetaxel—ovarian cancer	0.00131	0.00197	CcSEcCtD
Diflunisal—Nausea—Vinorelbine—ovarian cancer	0.00131	0.00196	CcSEcCtD
Diflunisal—Renal failure—Epirubicin—ovarian cancer	0.00131	0.00196	CcSEcCtD
Diflunisal—Dyspepsia—Paclitaxel—ovarian cancer	0.00131	0.00196	CcSEcCtD
Diflunisal—Jaundice—Epirubicin—ovarian cancer	0.0013	0.00194	CcSEcCtD
Diflunisal—Stomatitis—Epirubicin—ovarian cancer	0.0013	0.00194	CcSEcCtD
Diflunisal—Dysuria—Doxorubicin—ovarian cancer	0.00129	0.00193	CcSEcCtD
Diflunisal—Decreased appetite—Paclitaxel—ovarian cancer	0.00129	0.00193	CcSEcCtD
Diflunisal—Fatigue—Paclitaxel—ovarian cancer	0.00128	0.00192	CcSEcCtD
Diflunisal—Sweating—Epirubicin—ovarian cancer	0.00128	0.00191	CcSEcCtD
Diflunisal—Constipation—Paclitaxel—ovarian cancer	0.00127	0.0019	CcSEcCtD
Diflunisal—Haematuria—Epirubicin—ovarian cancer	0.00127	0.0019	CcSEcCtD
Diflunisal—Confusional state—Docetaxel—ovarian cancer	0.00127	0.0019	CcSEcCtD
Diflunisal—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.00126	0.00189	CcSEcCtD
Diflunisal—Anaphylactic shock—Docetaxel—ovarian cancer	0.00126	0.00188	CcSEcCtD
Diflunisal—Oedema—Docetaxel—ovarian cancer	0.00126	0.00188	CcSEcCtD
Diflunisal—Agranulocytosis—Epirubicin—ovarian cancer	0.00124	0.00186	CcSEcCtD
Diflunisal—Shock—Docetaxel—ovarian cancer	0.00124	0.00185	CcSEcCtD
Diflunisal—Thrombocytopenia—Docetaxel—ovarian cancer	0.00123	0.00184	CcSEcCtD
Diflunisal—Feeling abnormal—Paclitaxel—ovarian cancer	0.00122	0.00183	CcSEcCtD
Diflunisal—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.00122	0.00183	CcSEcCtD
Diflunisal—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.00121	0.00182	CcSEcCtD
Diflunisal—Renal failure—Doxorubicin—ovarian cancer	0.00121	0.00181	CcSEcCtD
Diflunisal—Stomatitis—Doxorubicin—ovarian cancer	0.0012	0.0018	CcSEcCtD
Diflunisal—Jaundice—Doxorubicin—ovarian cancer	0.0012	0.0018	CcSEcCtD
Diflunisal—Anorexia—Docetaxel—ovarian cancer	0.0012	0.0018	CcSEcCtD
Diflunisal—Hepatitis—Epirubicin—ovarian cancer	0.00119	0.00179	CcSEcCtD
Diflunisal—Sweating—Doxorubicin—ovarian cancer	0.00118	0.00177	CcSEcCtD
Diflunisal—Urticaria—Paclitaxel—ovarian cancer	0.00118	0.00177	CcSEcCtD
Diflunisal—Haematuria—Doxorubicin—ovarian cancer	0.00117	0.00176	CcSEcCtD
Diflunisal—Body temperature increased—Paclitaxel—ovarian cancer	0.00117	0.00176	CcSEcCtD
Diflunisal—Visual impairment—Epirubicin—ovarian cancer	0.00115	0.00172	CcSEcCtD
Diflunisal—Agranulocytosis—Doxorubicin—ovarian cancer	0.00115	0.00172	CcSEcCtD
Diflunisal—Insomnia—Docetaxel—ovarian cancer	0.00114	0.0017	CcSEcCtD
Diflunisal—Paraesthesia—Docetaxel—ovarian cancer	0.00113	0.00169	CcSEcCtD
Diflunisal—Erythema multiforme—Epirubicin—ovarian cancer	0.00113	0.00169	CcSEcCtD
Diflunisal—Dyspnoea—Docetaxel—ovarian cancer	0.00112	0.00168	CcSEcCtD
Diflunisal—Somnolence—Docetaxel—ovarian cancer	0.00112	0.00167	CcSEcCtD
Diflunisal—Tinnitus—Epirubicin—ovarian cancer	0.00111	0.00167	CcSEcCtD
Diflunisal—Flushing—Epirubicin—ovarian cancer	0.00111	0.00166	CcSEcCtD
Diflunisal—Dyspepsia—Docetaxel—ovarian cancer	0.00111	0.00166	CcSEcCtD
Diflunisal—Hepatitis—Doxorubicin—ovarian cancer	0.0011	0.00166	CcSEcCtD
Diflunisal—Decreased appetite—Docetaxel—ovarian cancer	0.00109	0.00164	CcSEcCtD
Diflunisal—Hypersensitivity—Paclitaxel—ovarian cancer	0.00109	0.00164	CcSEcCtD
Diflunisal—Fatigue—Docetaxel—ovarian cancer	0.00108	0.00162	CcSEcCtD
Diflunisal—Constipation—Docetaxel—ovarian cancer	0.00108	0.00161	CcSEcCtD
Diflunisal—Visual impairment—Doxorubicin—ovarian cancer	0.00106	0.00159	CcSEcCtD
Diflunisal—Asthenia—Paclitaxel—ovarian cancer	0.00106	0.00159	CcSEcCtD
Diflunisal—Pruritus—Paclitaxel—ovarian cancer	0.00105	0.00157	CcSEcCtD
Diflunisal—Erythema multiforme—Doxorubicin—ovarian cancer	0.00104	0.00156	CcSEcCtD
Diflunisal—Feeling abnormal—Docetaxel—ovarian cancer	0.00104	0.00155	CcSEcCtD
Diflunisal—Tinnitus—Doxorubicin—ovarian cancer	0.00103	0.00154	CcSEcCtD
Diflunisal—Gastrointestinal pain—Docetaxel—ovarian cancer	0.00103	0.00154	CcSEcCtD
Diflunisal—Flushing—Doxorubicin—ovarian cancer	0.00103	0.00154	CcSEcCtD
Diflunisal—Flatulence—Epirubicin—ovarian cancer	0.00102	0.00153	CcSEcCtD
Diflunisal—Tension—Epirubicin—ovarian cancer	0.00102	0.00153	CcSEcCtD
Diflunisal—Diarrhoea—Paclitaxel—ovarian cancer	0.00102	0.00152	CcSEcCtD
Diflunisal—Nervousness—Epirubicin—ovarian cancer	0.00101	0.00151	CcSEcCtD
Diflunisal—Muscle spasms—Epirubicin—ovarian cancer	0.000999	0.0015	CcSEcCtD
Diflunisal—Body temperature increased—Docetaxel—ovarian cancer	0.000994	0.00149	CcSEcCtD
Diflunisal—Dizziness—Paclitaxel—ovarian cancer	0.000981	0.00147	CcSEcCtD
Diflunisal—Vision blurred—Epirubicin—ovarian cancer	0.00098	0.00147	CcSEcCtD
Diflunisal—Flatulence—Doxorubicin—ovarian cancer	0.000948	0.00142	CcSEcCtD
Diflunisal—Tension—Doxorubicin—ovarian cancer	0.000944	0.00141	CcSEcCtD
Diflunisal—Vomiting—Paclitaxel—ovarian cancer	0.000944	0.00141	CcSEcCtD
Diflunisal—Rash—Paclitaxel—ovarian cancer	0.000936	0.0014	CcSEcCtD
Diflunisal—Dermatitis—Paclitaxel—ovarian cancer	0.000935	0.0014	CcSEcCtD
Diflunisal—Nervousness—Doxorubicin—ovarian cancer	0.000934	0.0014	CcSEcCtD
Diflunisal—Vertigo—Epirubicin—ovarian cancer	0.000934	0.0014	CcSEcCtD
Diflunisal—Syncope—Epirubicin—ovarian cancer	0.000932	0.0014	CcSEcCtD
Diflunisal—Headache—Paclitaxel—ovarian cancer	0.00093	0.00139	CcSEcCtD
Diflunisal—Hypersensitivity—Docetaxel—ovarian cancer	0.000927	0.00139	CcSEcCtD
Diflunisal—Muscle spasms—Doxorubicin—ovarian cancer	0.000925	0.00139	CcSEcCtD
Diflunisal—Palpitations—Epirubicin—ovarian cancer	0.000919	0.00138	CcSEcCtD
Diflunisal—Loss of consciousness—Epirubicin—ovarian cancer	0.000914	0.00137	CcSEcCtD
Diflunisal—Vision blurred—Doxorubicin—ovarian cancer	0.000906	0.00136	CcSEcCtD
Diflunisal—Asthenia—Docetaxel—ovarian cancer	0.000902	0.00135	CcSEcCtD
Diflunisal—Pruritus—Docetaxel—ovarian cancer	0.00089	0.00133	CcSEcCtD
Diflunisal—Chest pain—Epirubicin—ovarian cancer	0.000885	0.00133	CcSEcCtD
Diflunisal—Nausea—Paclitaxel—ovarian cancer	0.000881	0.00132	CcSEcCtD
Diflunisal—Vertigo—Doxorubicin—ovarian cancer	0.000864	0.00129	CcSEcCtD
Diflunisal—Syncope—Doxorubicin—ovarian cancer	0.000863	0.00129	CcSEcCtD
Diflunisal—Diarrhoea—Docetaxel—ovarian cancer	0.000861	0.00129	CcSEcCtD
Diflunisal—Confusional state—Epirubicin—ovarian cancer	0.000855	0.00128	CcSEcCtD
Diflunisal—Palpitations—Doxorubicin—ovarian cancer	0.00085	0.00127	CcSEcCtD
Diflunisal—Oedema—Epirubicin—ovarian cancer	0.000848	0.00127	CcSEcCtD
Diflunisal—Anaphylactic shock—Epirubicin—ovarian cancer	0.000848	0.00127	CcSEcCtD
Diflunisal—Loss of consciousness—Doxorubicin—ovarian cancer	0.000845	0.00127	CcSEcCtD
Diflunisal—Shock—Epirubicin—ovarian cancer	0.000835	0.00125	CcSEcCtD
Diflunisal—Dizziness—Docetaxel—ovarian cancer	0.000832	0.00125	CcSEcCtD
Diflunisal—Thrombocytopenia—Epirubicin—ovarian cancer	0.000831	0.00124	CcSEcCtD
Diflunisal—Hyperhidrosis—Epirubicin—ovarian cancer	0.00082	0.00123	CcSEcCtD
Diflunisal—Chest pain—Doxorubicin—ovarian cancer	0.000819	0.00123	CcSEcCtD
Diflunisal—Anorexia—Epirubicin—ovarian cancer	0.000809	0.00121	CcSEcCtD
Diflunisal—Vomiting—Docetaxel—ovarian cancer	0.0008	0.0012	CcSEcCtD
Diflunisal—Rash—Docetaxel—ovarian cancer	0.000793	0.00119	CcSEcCtD
Diflunisal—Dermatitis—Docetaxel—ovarian cancer	0.000792	0.00119	CcSEcCtD
Diflunisal—Confusional state—Doxorubicin—ovarian cancer	0.000792	0.00119	CcSEcCtD
Diflunisal—Headache—Docetaxel—ovarian cancer	0.000788	0.00118	CcSEcCtD
Diflunisal—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000785	0.00118	CcSEcCtD
Diflunisal—Oedema—Doxorubicin—ovarian cancer	0.000785	0.00118	CcSEcCtD
Diflunisal—Shock—Doxorubicin—ovarian cancer	0.000772	0.00116	CcSEcCtD
Diflunisal—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000769	0.00115	CcSEcCtD
Diflunisal—Insomnia—Epirubicin—ovarian cancer	0.000767	0.00115	CcSEcCtD
Diflunisal—Paraesthesia—Epirubicin—ovarian cancer	0.000762	0.00114	CcSEcCtD
Diflunisal—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000759	0.00114	CcSEcCtD
Diflunisal—Dyspnoea—Epirubicin—ovarian cancer	0.000756	0.00113	CcSEcCtD
Diflunisal—Somnolence—Epirubicin—ovarian cancer	0.000754	0.00113	CcSEcCtD
Diflunisal—Anorexia—Doxorubicin—ovarian cancer	0.000748	0.00112	CcSEcCtD
Diflunisal—Nausea—Docetaxel—ovarian cancer	0.000747	0.00112	CcSEcCtD
Diflunisal—Dyspepsia—Epirubicin—ovarian cancer	0.000747	0.00112	CcSEcCtD
Diflunisal—Decreased appetite—Epirubicin—ovarian cancer	0.000738	0.0011	CcSEcCtD
Diflunisal—Fatigue—Epirubicin—ovarian cancer	0.000731	0.0011	CcSEcCtD
Diflunisal—Constipation—Epirubicin—ovarian cancer	0.000726	0.00109	CcSEcCtD
Diflunisal—Insomnia—Doxorubicin—ovarian cancer	0.00071	0.00106	CcSEcCtD
Diflunisal—Paraesthesia—Doxorubicin—ovarian cancer	0.000705	0.00106	CcSEcCtD
Diflunisal—Dyspnoea—Doxorubicin—ovarian cancer	0.0007	0.00105	CcSEcCtD
Diflunisal—Feeling abnormal—Epirubicin—ovarian cancer	0.000699	0.00105	CcSEcCtD
Diflunisal—Somnolence—Doxorubicin—ovarian cancer	0.000698	0.00105	CcSEcCtD
Diflunisal—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000694	0.00104	CcSEcCtD
Diflunisal—Dyspepsia—Doxorubicin—ovarian cancer	0.000691	0.00104	CcSEcCtD
Diflunisal—Decreased appetite—Doxorubicin—ovarian cancer	0.000682	0.00102	CcSEcCtD
Diflunisal—Fatigue—Doxorubicin—ovarian cancer	0.000677	0.00101	CcSEcCtD
Diflunisal—Urticaria—Epirubicin—ovarian cancer	0.000674	0.00101	CcSEcCtD
Diflunisal—Constipation—Doxorubicin—ovarian cancer	0.000671	0.00101	CcSEcCtD
Diflunisal—Body temperature increased—Epirubicin—ovarian cancer	0.000671	0.001	CcSEcCtD
Diflunisal—Feeling abnormal—Doxorubicin—ovarian cancer	0.000647	0.000969	CcSEcCtD
Diflunisal—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000642	0.000962	CcSEcCtD
Diflunisal—Hypersensitivity—Epirubicin—ovarian cancer	0.000625	0.000936	CcSEcCtD
Diflunisal—Urticaria—Doxorubicin—ovarian cancer	0.000624	0.000934	CcSEcCtD
Diflunisal—Body temperature increased—Doxorubicin—ovarian cancer	0.000621	0.00093	CcSEcCtD
Diflunisal—Asthenia—Epirubicin—ovarian cancer	0.000609	0.000912	CcSEcCtD
Diflunisal—Pruritus—Epirubicin—ovarian cancer	0.0006	0.000899	CcSEcCtD
Diflunisal—Diarrhoea—Epirubicin—ovarian cancer	0.00058	0.00087	CcSEcCtD
Diflunisal—Hypersensitivity—Doxorubicin—ovarian cancer	0.000578	0.000866	CcSEcCtD
Diflunisal—Asthenia—Doxorubicin—ovarian cancer	0.000563	0.000844	CcSEcCtD
Diflunisal—Dizziness—Epirubicin—ovarian cancer	0.000561	0.00084	CcSEcCtD
Diflunisal—Pruritus—Doxorubicin—ovarian cancer	0.000555	0.000832	CcSEcCtD
Diflunisal—Vomiting—Epirubicin—ovarian cancer	0.000539	0.000808	CcSEcCtD
Diflunisal—Diarrhoea—Doxorubicin—ovarian cancer	0.000537	0.000805	CcSEcCtD
Diflunisal—Rash—Epirubicin—ovarian cancer	0.000535	0.000801	CcSEcCtD
Diflunisal—Dermatitis—Epirubicin—ovarian cancer	0.000534	0.000801	CcSEcCtD
Diflunisal—Headache—Epirubicin—ovarian cancer	0.000531	0.000796	CcSEcCtD
Diflunisal—Dizziness—Doxorubicin—ovarian cancer	0.000519	0.000778	CcSEcCtD
Diflunisal—Nausea—Epirubicin—ovarian cancer	0.000504	0.000755	CcSEcCtD
Diflunisal—Vomiting—Doxorubicin—ovarian cancer	0.000499	0.000748	CcSEcCtD
Diflunisal—Rash—Doxorubicin—ovarian cancer	0.000495	0.000741	CcSEcCtD
Diflunisal—Dermatitis—Doxorubicin—ovarian cancer	0.000495	0.000741	CcSEcCtD
Diflunisal—Headache—Doxorubicin—ovarian cancer	0.000492	0.000737	CcSEcCtD
Diflunisal—Nausea—Doxorubicin—ovarian cancer	0.000466	0.000698	CcSEcCtD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000237	0.00149	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CXCL8—ovarian cancer	0.000236	0.00148	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	0.000236	0.00148	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—MYC—ovarian cancer	0.000231	0.00145	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000231	0.00145	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CDKN1B—ovarian cancer	0.00023	0.00145	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PGR—ovarian cancer	0.000229	0.00143	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CASP3—ovarian cancer	0.000226	0.00142	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL2—ovarian cancer	0.000226	0.00142	CbGpPWpGaD
Diflunisal—PTGS2—Disease—BCL9—ovarian cancer	0.00022	0.00138	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CCND1—ovarian cancer	0.00022	0.00138	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000218	0.00137	CbGpPWpGaD
Diflunisal—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	0.000218	0.00137	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—KRAS—ovarian cancer	0.000214	0.00134	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MMP9—ovarian cancer	0.000213	0.00134	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—CAV1—ovarian cancer	0.000213	0.00133	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PARP1—ovarian cancer	0.000213	0.00133	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000212	0.00133	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—VEGFA—ovarian cancer	0.000212	0.00133	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—IL6—ovarian cancer	0.000211	0.00133	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	0.00021	0.00132	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000207	0.0013	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	0.000202	0.00127	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYTB—ovarian cancer	0.000198	0.00124	CbGpPWpGaD
Diflunisal—ALB—Metabolism—NME2—ovarian cancer	0.000197	0.00124	CbGpPWpGaD
Diflunisal—TTR—Disease—TERT—ovarian cancer	0.000196	0.00123	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CG—ovarian cancer	0.000194	0.00122	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000193	0.00121	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000191	0.0012	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000187	0.00117	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TP53—ovarian cancer	0.000187	0.00117	CbGpPWpGaD
Diflunisal—PTGS2—C-MYB transcription factor network—HRAS—ovarian cancer	0.000182	0.00114	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MAPK3—ovarian cancer	0.000181	0.00114	CbGpPWpGaD
Diflunisal—TTR—Disease—CAV1—ovarian cancer	0.000181	0.00114	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MYC—ovarian cancer	0.000176	0.00111	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—BRIP1—ovarian cancer	0.000173	0.00108	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PPP1CC—ovarian cancer	0.000173	0.00108	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MAPK1—ovarian cancer	0.000173	0.00108	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—EGFR—ovarian cancer	0.000173	0.00108	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PPP2R1A—ovarian cancer	0.000172	0.00108	CbGpPWpGaD
Diflunisal—TTR—Disease—IL6ST—ovarian cancer	0.000172	0.00108	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—IL6—ovarian cancer	0.000171	0.00107	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CD—ovarian cancer	0.00017	0.00107	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000169	0.00106	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000168	0.00106	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—IL6—ovarian cancer	0.000168	0.00105	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SPARC—ovarian cancer	0.000167	0.00105	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000167	0.00105	CbGpPWpGaD
Diflunisal—TTR—Disease—APC—ovarian cancer	0.000165	0.00103	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PPP1CC—ovarian cancer	0.000164	0.00103	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	0.000157	0.000985	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYTB—ovarian cancer	0.000157	0.000985	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000157	0.000984	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000154	0.000964	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000153	0.000963	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.00015	0.000939	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CB—ovarian cancer	0.000148	0.000931	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000148	0.00093	CbGpPWpGaD
Diflunisal—TTR—Disease—PIK3CD—ovarian cancer	0.000145	0.000909	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TP53—ovarian cancer	0.000145	0.000909	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000144	0.000906	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	0.000138	0.000866	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—BRIP1—ovarian cancer	0.000137	0.000861	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PPP1CC—ovarian cancer	0.000137	0.000861	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TERT—ovarian cancer	0.000137	0.00086	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000136	0.000855	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	0.000136	0.000851	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—IL6—ovarian cancer	0.000133	0.000832	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.00013	0.000818	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTEN—ovarian cancer	0.000128	0.000805	CbGpPWpGaD
Diflunisal—TTR—Disease—ERBB2—ovarian cancer	0.000128	0.000803	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000127	0.0008	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYTB—ovarian cancer	0.000127	0.000797	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CAV1—ovarian cancer	0.000127	0.000795	CbGpPWpGaD
Diflunisal—TTR—Disease—PIK3CB—ovarian cancer	0.000126	0.000792	CbGpPWpGaD
Diflunisal—TTR—Disease—MTOR—ovarian cancer	0.000126	0.000792	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000126	0.00079	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HDAC6—ovarian cancer	0.000124	0.000779	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000124	0.000779	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000123	0.000774	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000123	0.000772	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ESR1—ovarian cancer	0.000122	0.000766	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SOD1—ovarian cancer	0.000121	0.000762	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PPP2R1A—ovarian cancer	0.000121	0.000759	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	0.00012	0.000755	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL6ST—ovarian cancer	0.00012	0.000754	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.00012	0.000753	CbGpPWpGaD
Diflunisal—TTR—Disease—CDKN1B—ovarian cancer	0.000119	0.000744	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000117	0.000737	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000117	0.000736	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—YAP1—ovarian cancer	0.000116	0.000727	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—APC—ovarian cancer	0.000115	0.000724	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CG—ovarian cancer	0.000115	0.000724	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000115	0.00072	CbGpPWpGaD
Diflunisal—TTR—Disease—CTNNB1—ovarian cancer	0.000112	0.000703	CbGpPWpGaD
Diflunisal—ALB—Metabolism—BRIP1—ovarian cancer	0.000111	0.000696	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PPP1CC—ovarian cancer	0.000111	0.000696	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000111	0.000696	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	0.00011	0.000693	CbGpPWpGaD
Diflunisal—TTR—Disease—PTEN—ovarian cancer	0.000109	0.000685	CbGpPWpGaD
Diflunisal—PTGS2—Disease—XIAP—ovarian cancer	0.000108	0.000675	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SMARCA4—ovarian cancer	0.000105	0.000658	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EREG—ovarian cancer	0.000102	0.000642	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000102	0.000639	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CD—ovarian cancer	0.000101	0.000637	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000101	0.000633	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.0001	0.000627	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	9.85e-05	0.000618	CbGpPWpGaD
Diflunisal—TTR—Disease—STAT3—ovarian cancer	9.76e-05	0.000612	CbGpPWpGaD
Diflunisal—TTR—Disease—NRAS—ovarian cancer	9.73e-05	0.000611	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.72e-05	0.00061	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—FASN—ovarian cancer	9.45e-05	0.000593	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	9.39e-05	0.000589	CbGpPWpGaD
Diflunisal—TTR—Disease—MAPK3—ovarian cancer	9.32e-05	0.000585	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SLC5A5—ovarian cancer	9.29e-05	0.000583	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—YAP1—ovarian cancer	9.2e-05	0.000577	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.1e-05	0.000571	CbGpPWpGaD
Diflunisal—TTR—Disease—MYC—ovarian cancer	9.07e-05	0.000569	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PIK3CA—ovarian cancer	9.05e-05	0.000568	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SLC2A1—ovarian cancer	8.98e-05	0.000563	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ERBB2—ovarian cancer	8.96e-05	0.000562	CbGpPWpGaD
Diflunisal—PTGS2—Disease—FASN—ovarian cancer	8.96e-05	0.000562	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PARP1—ovarian cancer	8.92e-05	0.00056	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—CAV1—ovarian cancer	8.88e-05	0.000557	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	8.88e-05	0.000557	CbGpPWpGaD
Diflunisal—TTR—Disease—MAPK1—ovarian cancer	8.87e-05	0.000557	CbGpPWpGaD
Diflunisal—TTR—Disease—EGFR—ovarian cancer	8.87e-05	0.000557	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CB—ovarian cancer	8.84e-05	0.000555	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MTOR—ovarian cancer	8.84e-05	0.000555	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.79e-05	0.000551	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CYP1B1—ovarian cancer	8.6e-05	0.00054	CbGpPWpGaD
Diflunisal—PTGS2—Disease—SLC2A1—ovarian cancer	8.51e-05	0.000534	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CXCL8—ovarian cancer	8.5e-05	0.000533	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	8.45e-05	0.00053	CbGpPWpGaD
Diflunisal—TTR—Disease—KRAS—ovarian cancer	8.38e-05	0.000526	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	8.32e-05	0.000522	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CDKN1B—ovarian cancer	8.3e-05	0.000521	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CASP3—ovarian cancer	8.13e-05	0.00051	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL2—ovarian cancer	8.12e-05	0.00051	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CG—ovarian cancer	8.09e-05	0.000508	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	8.09e-05	0.000507	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8e-05	0.000502	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CCND1—ovarian cancer	7.92e-05	0.000497	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CTNNB1—ovarian cancer	7.84e-05	0.000492	CbGpPWpGaD
Diflunisal—TTR—Disease—PIK3CA—ovarian cancer	7.7e-05	0.000483	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MMP9—ovarian cancer	7.69e-05	0.000482	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PTEN—ovarian cancer	7.64e-05	0.000479	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PPP2R1A—ovarian cancer	7.63e-05	0.000479	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	7.59e-05	0.000477	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—FASN—ovarian cancer	7.5e-05	0.000471	CbGpPWpGaD
Diflunisal—ALB—Metabolism—YAP1—ovarian cancer	7.44e-05	0.000467	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—AKT1—ovarian cancer	7.39e-05	0.000464	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SLC5A5—ovarian cancer	7.38e-05	0.000463	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	7.37e-05	0.000462	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	7.33e-05	0.00046	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PPP2R1A—ovarian cancer	7.23e-05	0.000454	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SLC2A1—ovarian cancer	7.12e-05	0.000447	CbGpPWpGaD
Diflunisal—TTR—Disease—HRAS—ovarian cancer	7.12e-05	0.000447	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CD—ovarian cancer	7.11e-05	0.000446	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—ABCB1—ovarian cancer	7.09e-05	0.000445	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	6.98e-05	0.000438	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—TYMS—ovarian cancer	6.96e-05	0.000437	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—VEGFA—ovarian cancer	6.9e-05	0.000433	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—STAT3—ovarian cancer	6.83e-05	0.000429	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CYP1B1—ovarian cancer	6.83e-05	0.000429	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—NRAS—ovarian cancer	6.82e-05	0.000428	CbGpPWpGaD
Diflunisal—TTR—Disease—IL6—ovarian cancer	6.82e-05	0.000428	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MAPK3—ovarian cancer	6.53e-05	0.00041	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	6.48e-05	0.000406	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MYC—ovarian cancer	6.35e-05	0.000398	CbGpPWpGaD
Diflunisal—TTR—Disease—AKT1—ovarian cancer	6.29e-05	0.000395	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MAPK1—ovarian cancer	6.21e-05	0.00039	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—EGFR—ovarian cancer	6.21e-05	0.00039	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CB—ovarian cancer	6.2e-05	0.000389	CbGpPWpGaD
Diflunisal—ALB—Metabolism—FASN—ovarian cancer	6.07e-05	0.000381	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PPP2R1A—ovarian cancer	6.06e-05	0.00038	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.03e-05	0.000378	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	5.99e-05	0.000376	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC5A5—ovarian cancer	5.97e-05	0.000375	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—KRAS—ovarian cancer	5.87e-05	0.000368	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SLC2A1—ovarian cancer	5.76e-05	0.000362	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TERT—ovarian cancer	5.75e-05	0.000361	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IL2—ovarian cancer	5.69e-05	0.000357	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	5.64e-05	0.000354	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—ABCB1—ovarian cancer	5.63e-05	0.000353	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CAV1—ovarian cancer	5.61e-05	0.000352	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CYP1B1—ovarian cancer	5.53e-05	0.000347	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—TYMS—ovarian cancer	5.52e-05	0.000347	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PIK3CA—ovarian cancer	5.39e-05	0.000338	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.36e-05	0.000336	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CAV1—ovarian cancer	5.32e-05	0.000334	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TP53—ovarian cancer	5.21e-05	0.000327	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CG—ovarian cancer	5.11e-05	0.000321	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6ST—ovarian cancer	5.04e-05	0.000316	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—HRAS—ovarian cancer	4.99e-05	0.000313	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PPP2R1A—ovarian cancer	4.9e-05	0.000308	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	4.88e-05	0.000306	CbGpPWpGaD
Diflunisal—PTGS2—Disease—APC—ovarian cancer	4.84e-05	0.000304	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VEGFA—ovarian cancer	4.84e-05	0.000304	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—NRAS—ovarian cancer	4.78e-05	0.0003	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IL6—ovarian cancer	4.77e-05	0.0003	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MAPK3—ovarian cancer	4.58e-05	0.000287	CbGpPWpGaD
Diflunisal—ALB—Metabolism—ABCB1—ovarian cancer	4.55e-05	0.000286	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CD—ovarian cancer	4.49e-05	0.000282	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TYMS—ovarian cancer	4.47e-05	0.00028	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CAV1—ovarian cancer	4.45e-05	0.000279	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—AKT1—ovarian cancer	4.4e-05	0.000276	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—MAPK1—ovarian cancer	4.36e-05	0.000273	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CD—ovarian cancer	4.26e-05	0.000267	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.25e-05	0.000267	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—KRAS—ovarian cancer	4.11e-05	0.000258	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CG—ovarian cancer	4.05e-05	0.000254	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CB—ovarian cancer	3.91e-05	0.000246	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PIK3CA—ovarian cancer	3.78e-05	0.000237	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ERBB2—ovarian cancer	3.76e-05	0.000236	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MTOR—ovarian cancer	3.71e-05	0.000233	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CB—ovarian cancer	3.71e-05	0.000233	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TP53—ovarian cancer	3.66e-05	0.000229	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CAV1—ovarian cancer	3.6e-05	0.000226	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CD—ovarian cancer	3.56e-05	0.000224	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—HRAS—ovarian cancer	3.5e-05	0.000219	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CDKN1B—ovarian cancer	3.48e-05	0.000218	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	3.44e-05	0.000216	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTEN—ovarian cancer	3.38e-05	0.000212	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CTNNB1—ovarian cancer	3.29e-05	0.000206	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CG—ovarian cancer	3.28e-05	0.000206	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PTEN—ovarian cancer	3.21e-05	0.000201	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CB—ovarian cancer	3.11e-05	0.000195	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—AKT1—ovarian cancer	3.09e-05	0.000194	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CD—ovarian cancer	2.88e-05	0.000181	CbGpPWpGaD
Diflunisal—PTGS2—Disease—STAT3—ovarian cancer	2.87e-05	0.00018	CbGpPWpGaD
Diflunisal—PTGS2—Disease—NRAS—ovarian cancer	2.86e-05	0.000179	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MAPK3—ovarian cancer	2.74e-05	0.000172	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PTEN—ovarian cancer	2.68e-05	0.000168	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MYC—ovarian cancer	2.66e-05	0.000167	CbGpPWpGaD
Diflunisal—PTGS2—Disease—MAPK1—ovarian cancer	2.61e-05	0.000164	CbGpPWpGaD
Diflunisal—PTGS2—Disease—EGFR—ovarian cancer	2.61e-05	0.000164	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CB—ovarian cancer	2.51e-05	0.000158	CbGpPWpGaD
Diflunisal—PTGS2—Disease—KRAS—ovarian cancer	2.46e-05	0.000154	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PIK3CA—ovarian cancer	2.39e-05	0.00015	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PIK3CA—ovarian cancer	2.26e-05	0.000142	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTEN—ovarian cancer	2.17e-05	0.000136	CbGpPWpGaD
Diflunisal—PTGS2—Disease—HRAS—ovarian cancer	2.09e-05	0.000131	CbGpPWpGaD
Diflunisal—PTGS2—Disease—IL6—ovarian cancer	2e-05	0.000126	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—AKT1—ovarian cancer	1.95e-05	0.000122	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PIK3CA—ovarian cancer	1.89e-05	0.000119	CbGpPWpGaD
Diflunisal—PTGS2—Disease—AKT1—ovarian cancer	1.85e-05	0.000116	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—AKT1—ovarian cancer	1.55e-05	9.71e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PIK3CA—ovarian cancer	1.53e-05	9.62e-05	CbGpPWpGaD
Diflunisal—ALB—Metabolism—AKT1—ovarian cancer	1.25e-05	7.86e-05	CbGpPWpGaD
